The national advisory committee for the licensing of the Covid-19 vaccine has met on Thursday in Rabat to discuss the authorization of AstraZeneca’s vaccine in Morocco.
During the meeting, the national committee reviewed all international information and data concerning AstraZeneca’s Covid-19 vaccine, Bouchra Meddah, Director of Medicines and Pharmacy at the Ministry of Health told reporters.
The committee is studying the vaccine’s compliance with manufacturing, safety, quality and efficacy standards, the results of pre-clinical and clinical trials as well as the international approval of the vaccine, she said at the end of the meeting.
The British Medicines and Healthcare products Regulatory Agency has given the go-ahead for the marketing of the vaccine, the official added, noting that Morocco has adopted the WHO procedure for licensing the vaccine for use in case of health emergency.
According to Moulay Mustapha Ennaji, director of the virology laboratory at the Hassan II-Casablanca University, “the committee will make a final decision on this vaccine as soon as possible.”
For his part, Azeddine Ibrahimi, director of the biotechnology laboratory of the Faculty of Medicine and Pharmacy in Rabat, recalled that the Sinopharm and AstraZeneca vaccines were approved for use by the governments of their countries of origin.
The national committee is studying the data related to the AstraZeneca vaccine to make the appropriate decision in full transparency, he added.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.